atai Life Sciences Completes Phase 2b TRD Trial Enrollment
Atai Life Sciences (NASDAQ: ATAI), a leader in the biopharmaceutical sector, has successfully completed patient enrollment for the core stage... Lire la suite
March 10, 2025
Uncover the latest trends and breakthroughs in financial technology with our Fintech category. Here, we summarize crucial developments from our partner companies, providing a window into innovations reshaping the world of finance.
© Copyright BRKFST Club management co.